| Literature DB >> 35061958 |
Tao-Hsin Tung1, Xiao-Qing Lin2, Yan Chen2, Hongwei Wu2, Mei-Xian Zhang1,3, Jian-Sheng Zhu2.
Abstract
PURPOSE: This population-based cross-sectional study was conducted to explore whether parents are willing to pay to vaccinate their children against COVID-19 in China.Entities:
Keywords: COVID-19; China; children; parents; willingness-to-vaccine
Mesh:
Substances:
Year: 2022 PMID: 35061958 PMCID: PMC8920241 DOI: 10.1080/21645515.2021.2014731
Source DB: PubMed Journal: Hum Vaccin Immunother ISSN: 2164-5515 Impact factor: 3.452
Figure 1.Framework for studying the outcome variables.
Figure 2.Association between parents’ willingness to pay for vaccination themselves and willingness to pay for vaccination their children.
Univariate analysis of factors associated with parents’ willingness to pay for a COVID-19 vaccine for their children (n = 1788)
| Variables | Categories | Parents ( | Fathers ( | Mothers ( | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Willingness to pay ( | Unwillingness to pay ( | Willingness to pay ( | Unwillingness to pay ( | Willingness to pay ( | Unwillingness to pay ( | |||||
| Sex | Men | 307 (26.0) | 141 (23.3) | .211 | 307 (100.0) | 141 (100.0) | / | / | / | / |
| Women | 875 (74.0) | 465 (76.7) | / | / | 875 (100.0) | 465 (100.0) | ||||
| Age (years)* | 42.0 ± 5.4 | 41.0 ± 4.9 | 43.9 ± 5.5 | 42.6 ± 5.2 | . | 41.4 ± 5.3 | 40.5 ± 4.7 | . | ||
| Residence | Rural | 286 (24.2) | 110 (18.2) | . | 84 (27.4) | 32 (22.7) | .577 | 202 (23.1) | 78 (16.8) | . |
| Town | 227 (19.2) | 116 (19.1) | 56 (18.2) | 27 (19.1) | 171 (19.5) | 89 (19.1) | ||||
| Urban | 669 (56.6) | 380 (62.7) | 167 (54.4) | 82 (58.2) | 502 (57.4) | 298 (64.1) | ||||
| Education level | Junior Secondary and below | 379 (32.1) | 145 (23.9) | 86 (28.0) | 35 (24.8) | .268 | 293 (33.5) | 110 (23.7) | ||
| Senior Secondary | 276 (23.4) | 136 (22.4) | 81 (26.4) | 28 (19.9) | 195 (22.3) | 108 (23.2) | ||||
| Junior College | 223 (18.9) | 111 (18.3) | 46 (15.0) | 26 (18.4) | 177 (20.2) | 85 (18.3) | ||||
| Undergraduate and above | 304 (25.7) | 214 (35.3) | 94 (30.6) | 52 (36.9) | 210 (24.0) | 162 (34.8) | ||||
| Occupation | Civil servant or professional technician or serviceman | 204 (17.3) | 122 (20.1) | .276 | 77 (25.1) | 41 (29.1) | .751 | 127 (14.5) | 81 (17.4) | .317 |
| Employees and managers of enterprises | 266 (22.5) | 149 (24.6) | 71 (23.1) | 36 (25.5) | 195 (22.3) | 113 (24.3) | ||||
| Workmen or farmer | 164 (13.9) | 67 (11.1) | 48 (15.6) | 16 (11.3) | 116 (13.3) | 51 (11.0) | ||||
| Freelancer | 186 (15.7) | 82 (13.5) | 29 (9.4) | 15 (10.6) | 157 (17.9) | 67 (14.4) | ||||
| Self employed | 207 (17.5) | 106 (17.5) | 59 (19.2) | 23 (16.3) | 148 (16.9) | 83 (17.8) | ||||
| Others | 155 (13.1) | 80 (13.2) | 23 (7.5) | 10 (7.1) | 132 (15.1) | 70 (15.1) | ||||
| One-child family | Yes | 610 (51.6) | 280 (46.2) | . | 158 (51.5) | 73 (51.8) | .952 | 452 (51.7) | 207 (44.5) | . |
| No | 572 (48.4) | 326 (53.8) | 149 (48.5) | 68 (48.2) | 423 (48.3) | 258 (55.5) | ||||
| First child’s grade | . | .636 | . | |||||||
| Primary below grade 3 | 160 (13.5) | 110 (18.2) | 44 (14.3) | 26 (18.4) | 116 (13.3) | 84 (18.1) | ||||
| Primary grade 4–6 | 182 (15.4) | 111 (18.3) | 41 (13.4) | 20 (14.2) | 141 (16.1) | 91 (19.6) | ||||
| Junior school | 276 (23.4) | 153 (25.2) | 68 (22.1) | 32 (22.7) | 208 (23.8) | 121 (26.0) | ||||
| Senior school | 564 (47.7) | 232 (38.3) | 154 (50.2) | 63 (44.7) | 410 (46.9) | 169 (36.3) | ||||
| Risk perception of COVID-19 | .319 | .369 | .594 | |||||||
| High risk | 125 (10.6) | 55 (9.1) | 42 (13.7) | 15 (10.6) | 83 (9.5) | 40 (8.6) | ||||
| Low risk | 1057 (89.4) | 551 (90.9) | 265 (86.3) | 126 (89.4) | 792 (90.5) | 425 (91.4) | ||||
| Score of knowledge about vaccination against COVID-19* | ||||||||||
| 44.7 ± 28.1 | 40.2 ± 28.2 | . | 43.4 ± 30.0 | 40.7 ± 30.9 | .375 | 45.1 ± 27.4 | 40.0 ± 27.4 | . | ||
| Are you aware that COVID-19 vaccine has been approved for emergency use in children under 18 years? | ||||||||||
| Yes | 857 (72.5) | 387 (63.9) | 235 (76.5) | 98 (69.5) | .113 | 622 (71.1) | 289 (62.2) | . | ||
| No | 325 (27.5) | 219 (36.1) | 72 (23.5) | 43 (30.5) | 253 (28.9) | 176 (37.8) | ||||
| Parents’ hesitancy to receive vaccines against COVID-19 | ||||||||||
| Yes | 459 (38.8) | 350 (57.8) | 91 (29.6) | 62 (44.0) | . | 368 (42.1) | 288 (61.9) | |||
| No | 723 (61.2) | 256 (42.2) | 216 (70.4) | 79 (56.0) | 507 (57.9) | 177 (38.1) | ||||
Data were expressed as number followed by proportion in the parentheses within parents’ willingness or unwillingness.
* Data on age and score of knowledge about vaccination against COVID-19 were continuous, expressed as mean ± standard deviation (SD), and compared the differences between willingness group and unwillingness group using t-test.
Multiple logistic regression of factors associated with parents’ willingness to pay for a COVID-19 vaccine for their children (n = 1788)
| Variables | Categories | Parents | Fathers | Mothers | |||
|---|---|---|---|---|---|---|---|
| Age (years)* | .729 | 0.99 (0.96–1.03) | .267 | 1.03 (0.98–1.08) | .329 | 0.98 (0.95–1.02) | |
| Residence | |||||||
| Rural vs. urban | .245 | 1.24 (0.86–1.79) | / | / | .192 | 1.33 (0.87–2.03) | |
| Town vs. urban | .530 | 1.11 (0.80–1.55) | / | / | .775 | 0.95 (0.65–1.38) | |
| Education level | Junior Secondary and below | 2.45 (1.63–3.68) | / | / | 2.43 (1.53–3.84) | ||
| Senior Secondary | 2.16 (1.49–3.12) | / | / | . | 1.88 (1.23–2.87) | ||
| Junior College | 1.93 (1.33–2.79) | / | / | 2.07 (1.35–3.16) | |||
| Undergraduate and above | / | 1 | / | / | / | 1 | |
| One-child family | Yes vs. no | . | 1.35 (1.04–1.74) | / | / | . | 1.58 (1.18–2.13) |
| First child’s grade | Primary below grade 3 vs. senior school | .155 | 0.72 (0.45–1.13) | / | / | . | 0.55 (0.32–0.93) |
| Primary grade 4–6 vs. senior school | .911 | 1.02 (0.67–1.56) | / | / | .631 | 0.89 (0.55–1.43) | |
| Junior school vs. senior school | .252 | 0.82 (0.58–1.15) | / | / | .129 | 0.74 (0.50–1.09) | |
| Score of knowledge about vaccination against COVID-19* | |||||||
| High vs. low | . | 1.31 (1.01–1.69) | / | / | .051 | 1.34 (0.99–1.80) | |
| Yes vs. No | . | 1.51 (1.16–1.97) | / | / | . | 1.53 (1.13–2.07) | |
| Parents’ hesitancy to receive vaccines against COVID-19 | |||||||
| No vs. Yes | .083 | 1.25 (0.97–1.61) | .808 | 0.94 (0.55–1.59) | . | 1.36 (1.02–1.82) | |
| Parents’ willingness to pay for a COVID-19 vaccine for themselves | |||||||
| Yes vs. No | 16.31 (12.59–21.14) | 18.12 (10.77–30.49) | 15.35 (11.41–20.64) | ||||
Multiple logistic regression of factors associated with parents’ willingness to pay for a COVID-19 vaccine for themselves that all univariate significant factors were included among study samples (n = 1788)
| Variables | Categories | Parents | Fathers | Mothers | |||
|---|---|---|---|---|---|---|---|
| Age (years) | / | .059 | 1.02 (0.99–1.04) | . | 1.04 (1.00–1.08) | .375 | 1.01 (0.99–1.03) |
| Score of knowledge about vaccination against COVID-19 | High vs. Low | 1.52 (1.24–1.86) | .221 | 1.29 (0.86–1.96) | 1.59 (1.26–2.01) | ||
| Risk perception of COVID-19 | High vs. Low | .468 | 0.88 (0.62–1.25) | . | 0.48 (0.23–0.98) | .641 | 1.10 (0.73–1.66) |
| Parents’ hesitancy to receive vaccines against COVID-19 | No vs. Yes | 2.72 (2.23–3.32) | 2.73 (1.80–4.14) | 2.78 (2.20–3.50) | |||
The estimates of parents’ willingness-to-pay to children vaccination in various vaccines and study populations
| Willingness to pay | ||||||||
|---|---|---|---|---|---|---|---|---|
| Author | Study design | Study period | Study sample | Country | Vaccine | Percent | Mean/Median | Reference |
| Catma et al. | Cross-sectional | 2021 | Total:584 | USA | COVID-19 | NA | mean:US $243-$321 | [ |
| Rezaei et al. | Cross-sectional | 2019 | Mother:667 | Iran | compulsory vaccination | Mother:93.1% | mean:US $4.4 | [ |
| Lai et al. | Cross-sectional | 2019 | Total:6668 | China | Influenza | Total:92.8% | mean: CNY $127.5median:CNY $ 150 | [ |
| Wagnew et al. | Cross-sectional | 2019 | Total: 604 | Ethiopia | Malaria | Total:60.6% | mean:US $23.11 | [ |
| Olson et al. | Cross-sectional | 2015–2016 | Total:564 | Guatemala | Norovirus | Total:97% | $0–$3.40:54%$3.40–$6.80:30%$6.80–$10.20:5%$10.20–$13.60:6%> $13.60:5% | [ |
| Hadisoemarto et al. | Proportional odds | 2010 | Total:500 | Indonesia | Dengue | Total:94.6% | mean:US $36.8 median:US $1.94 | [ |
| Iwashita et al. | Cross-sectional | 2010 | Total:549 | Japan | Hib | Total:50.3% | mean:JPY$2581 | [ |
| Muangchana et al. | Cross-sectional | 2006 | Mother:662 | Thailand | Hib | Mother:50% | median:THB $3800(US$106) | [ |
| Prosser et al. | Cross-sectional | 2015 | Total:101 | USA | Pneumococcal Conjugate | NA | median:US$100 – US$500 | [ |
| Dinh et al. | Cross-sectional | 2017 | Mother:606 | Vietnam | HPV | Mother:53.1% | >US $ 23:55.6%US $ 23-US $46:36.3%US $ 46-US $92:8.1% | [ |
| Umeh et al. | Cross-sectional | 2015 | Mother:438 | Nigeria | HPV | Mother:91.6% | mean:US $11.68WTP per dose:mean:US $ 5.84 median:US $ 5.03a dose US$ 5.03:50% | [ |
| Ngorsuracheset al. | Discrete choice | 2014 | Total: 314 | Thailand | HPV | NA | quadrivalent vaccine:Father:mean Baht$ 19260.5Mother:mean Baht$ 24493.1 bivalent vaccine:Father:mean Baht$ 9936.5 Mother:mean Baht$ 12,325.1 | [ |
| Kruiroongroj et al. | Cross-sectional | 2014 | Total:861 | Thailand | HPV | Total:Bivalent 68.9% | 3 doses of bivalent vaccine:N = 445<500 baht 159(35.8%) ≥500 baht 286 (64.3%)quadrivalent vaccine:N = 384Similar to bivalent vaccine 149 (38.8%)Higher than bivalent vaccine 235 (61.6%) | [ |
| Cerda et al. | Contingent valuation method | 2013 | Total:386 | Chile | HPV | Total:75% | mean:US $252.71 | [ |
| Brown et al. | Choice-format, | 2008 | Mother:307 | USA | HPV | NA | mean:US $560-$660 | [ |
| Liao et al. | Cross-sectional | 2007 | Mother:476 | Taiwan (China) | HPV | NA | median:US$1098 – US$1233 | [ |
NA, not available.